HomeCompareEFGIF vs MRK

EFGIF vs MRK: Dividend Comparison 2026

EFGIF yields 3.86% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EFGIF wins by $697.05M in total portfolio value
10 years
EFGIF
EFGIF
● Live price
3.86%
Share price
$21.47
Annual div
$0.83
5Y div CAGR
96%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$697.11M
Annual income
$657,054,058.78
Full EFGIF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — EFGIF vs MRK

📍 EFGIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEFGIFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EFGIF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EFGIF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EFGIF
Annual income on $10K today (after 15% tax)
$327.85/yr
After 10yr DRIP, annual income (after tax)
$558,495,949.96/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, EFGIF beats the other by $558,487,621.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EFGIF + MRK for your $10,000?

EFGIF: 50%MRK: 50%
100% MRK50/50100% EFGIF
Portfolio after 10yr
$348.58M
Annual income
$328,531,928.46/yr
Blended yield
94.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EFGIF
No analyst data
Altman Z
0.4
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EFGIF buys
0
MRK buys
0
No recent congressional trades found for EFGIF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEFGIFMRK
Forward yield3.86%2.76%
Annual dividend / share$0.83$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR96%32.7%
Portfolio after 10y$697.11M$56.8K
Annual income after 10y$657,054,058.78$9,798.13
Total dividends collected$694.17M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EFGIF vs MRK ($10,000, DRIP)

YearEFGIF PortfolioEFGIF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,456$755.97$11,206$366.19+$250.00EFGIF
2$13,844$1,586.39$12,650$502.35+$1.2KEFGIF
3$18,325$3,511.74$14,407$694.19+$3.9KEFGIF
4$28,123$8,514.72$16,585$967.82+$11.5KEFGIF
5$54,027$23,936.00$19,342$1,363.89+$34.7KEFGIF
6$142,042$84,232.68$22,913$1,947.19+$119.1KEFGIF
7$557,640$405,654.84$27,662$2,823.89+$530.0KEFGIF
8$3,513,876$2,917,201.50$34,159$4,173.35+$3.48MEFGIF
9$37,432,053$33,672,205.94$43,337$6,308.80+$37.39MEFGIF
10$697,106,356$657,054,058.78$56,776$9,798.13+$697.05MEFGIF

EFGIF vs MRK: Complete Analysis 2026

EFGIFStock

EFG International AG, together with its subsidiaries, provides private banking, wealth management, and asset management services. It offers investment solutions, including discretionary mandates, structured products, trading services, and Islamic solutions; wealth and trust services; credit and financing services, such as property and investment finance; and eBanking services, including mobile banking and security services. The company also provides other banking services consisting of custody, foreign exchange and treasury, and trading services, as well as accounts and cards; and supports independent asset managers to set up private label funds. It operates in Europe, Asia Pacific, the Americas, and the Middle East. EFG International AG was founded in 1995 and is headquartered in Zurich, Switzerland.

Full EFGIF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this EFGIF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EFGIF vs SCHDEFGIF vs JEPIEFGIF vs OEFGIF vs KOEFGIF vs MAINEFGIF vs JNJEFGIF vs ABBVEFGIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.